DYADIC INTERNATIONAL INC Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DYADIC INTERNATIONAL INC stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $115.80K, a 33.83% decline year-over-year.
- DYADIC INTERNATIONAL INC stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $436.61K, a 192.68% increase year-over-year.
- DYADIC INTERNATIONAL INC stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $175.00K.
- DYADIC INTERNATIONAL INC stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $149.18K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-03-31 | $115.80K 10-Q · filed 2021-05-13 | |
| 2020-06-30 | $436.61K 10-Q · filed 2020-11-12 | |
| 2020-03-31 | $175.00K 10-Q · filed 2021-05-13 | |
| 2019-06-30 | $149.18K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |